TP53 and neoplasm: Interestingly, T-cell responses were predominantly directed toward tumor-unrelated TP53 epitopes rather than the KRAS mutations present in the tumors, indicating the existence of a potential hierarchy of immunodominance in the processing and presentation of multiple epitopes within the same APCs.